Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Phio Pharmaceuticals Corp. PHIO

Full chart Compare
Set alert

Price alert · PHIO

All alert types
0.87 USD -0.03 (-3.67%)

At closeNov 4, 2026, 4:00 PM EST

0.85 -0.02 -2.29%

After hours · Nov 4, 4:00 PM ET

0.8619 Day range 0.9091
0.813 52-week range 1.88
YTD
-17.15%
1 year
-46.63%

Financial health

Altman Z-Score

-14.16 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -0.7×
FY 2016: -0.5×FY 2017: -1.0×FY 2018: -0.3×FY 2019: -0.5×FY 2020: -1.4×FY 2021: -1.0×FY 2022: -0.4×FY 2023: -0.1×FY 2024: -2.0×FY 2025: -0.7×
FY 2016 5y median -0.7× FY 2025
P/S 0.0×
FY 2016: 252×FY 2017: 836×FY 2018: 16.8×FY 2019: 206×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.3×
FY 2016: 0.4×FY 2017: 6.8×FY 2018: 0.2×FY 2019: 0.8×FY 2020: 0.9×FY 2021: 0.6×FY 2022: 0.5×FY 2023: 0.2×FY 2024: 0.3×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
P/FCF -0.8×
FY 2016: -0.6×FY 2017: -1.3×FY 2018: -0.3×FY 2019: -0.5×FY 2020: -1.4×FY 2021: -1.1×FY 2022: -0.4×FY 2023: -0.1×FY 2024: -0.2×FY 2025: -0.8×
FY 2016 5y median -0.4× FY 2025
EV/EBITDA 1.7×
FY 2016: 0.9×FY 2017: -0.6×FY 2018: 1.7×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.8×FY 2022: 0.6×FY 2023: 0.6×FY 2024: 0.6×FY 2025: 1.7×
FY 2016 5y median 0.6× FY 2025
EV/Sales 0.0×
FY 2016: -427×FY 2017: 598×FY 2018: -91.0×FY 2019: -99.4×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -127.2%
FY 2016: -161.8%FY 2017: -77.5%FY 2018: -324.3%FY 2019: -201.4%FY 2020: -71.6%FY 2021: -92.9%FY 2022: -241.7%FY 2023: -680.6%FY 2024: -501.8%FY 2025: -127.2%
FY 2016 5y median -241.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: -28400.0%FY 2017: -35700.0%FY 2018: -3034.8%FY 2019: 100.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -47447.4%FY 2017: -93746.7%FY 2018: -5336.2%FY 2019: -42795.2%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -47336.8%FY 2017: -83013.3%FY 2018: -5333.3%FY 2019: -42419.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -43.2%
FY 2016: -82.9%FY 2017: -679.3%FY 2018: -54.2%FY 2019: -155.0%FY 2020: -67.6%FY 2021: -60.6%FY 2022: -105.9%FY 2023: -140.1%FY 2024: -151.4%FY 2025: -43.2%
FY 2016 5y median -105.9% FY 2025
ROIC -43.8%
FY 2016: -82.4%FY 2017: -678.8%FY 2018: -54.2%FY 2019: -143.4%FY 2020: -64.4%FY 2021: -60.8%FY 2022: -104.1%FY 2023: -139.4%FY 2024: -156.4%FY 2025: -43.8%
FY 2016 5y median -104.1% FY 2025
ROA -40.5%
FY 2016: -67.1%FY 2017: -303.9%FY 2018: -48.0%FY 2019: -110.8%FY 2020: -55.9%FY 2021: -52.8%FY 2022: -89.6%FY 2023: -115.6%FY 2024: -124.6%FY 2025: -40.5%
FY 2016 5y median -89.6% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -44.1%FY 2017: -21.1%FY 2018: 820.0%FY 2019: -84.8%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -24.8%
FY 2016: 11.9%FY 2017: -56.0%FY 2018: 47.6%FY 2019: -22.0%FY 2020: 2.2%FY 2021: -53.7%FY 2022: 15.2%FY 2023: 5.6%FY 2024: 31.8%FY 2025: -24.8%
FY 2016 FY 2025
EPS (diluted) -59.3%
FY 2016: 14.8%FY 2017: 58.6%FY 2018: 81.0%FY 2019: 66.6%FY 2020: 90.0%FY 2021: 46.3%FY 2022: 19.5%FY 2023: 47.8%FY 2024: 98.1%FY 2025: -59.3%
FY 2016 FY 2025
Free Cash Flow -12.3%
FY 2016: -5.3%FY 2017: -25.2%FY 2018: 22.6%FY 2019: -15.8%FY 2020: -1.2%FY 2021: -35.0%FY 2022: -2.9%FY 2023: 12.2%FY 2024: 33.9%FY 2025: -12.3%
FY 2016 FY 2025

Financial Health

Current Ratio 49.4×
FY 2016: 5.2×FY 2017: 1.7×FY 2018: 8.7×FY 2019: 3.9×FY 2020: 6.9×FY 2021: 8.1×FY 2022: 6.4×FY 2023: 5.7×FY 2024: 5.7×FY 2025: 49.4×
FY 2016 5y median 6.4× FY 2025
Quick Ratio 49.4×
FY 2016: 5.2×FY 2017: 1.7×FY 2018: 8.7×FY 2019: 3.9×FY 2020: 6.9×FY 2021: 8.1×FY 2022: 6.4×FY 2023: 5.7×FY 2024: 5.7×FY 2025: 49.4×
FY 2016 5y median 6.4× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 2.4×
FY 2016: 1.4×FY 2017: 0.3×FY 2018: 2.0×FY 2019: 0.7×FY 2020: 1.6×FY 2021: 1.8×FY 2022: 1.0×FY 2023: 0.8×FY 2024: 0.8×FY 2025: 2.4×
FY 2016 5y median 1.0× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: -14062×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31